News Hub - Scientific and Academic News from Trusted Sources

Browse News by A-Z Index: ABCDEFGHIJKLMNOPQRSTUVWXYZ#0123456789

Only 35 percent assess patient's cardiac performance during high-risk surgery, study finds Source: HealthDay Related MedlinePlus Page: Surgery
A new study by researchers in Canada has found that many labor and delivery health professionals lack a clear understanding of the anesthesiologist's role as a physician with specialized skills in the management of seriously unwell pregnant patients. This role misconception may affect the quality of care delivered to mothers and their babies.
A pulse oximetry training video produced by Rafael Ortega, M.D., the vice-chair of academic affairs for the department of anesthesiology at Boston Medical Center and professor of anesthesiology at Boston University School of Medicine, and his colleagues is featured in this week's New England Journal of Medicine.
A pulse oximetry training video produced by Rafael Ortega, MD, the vice-chair of academic affairs for the department of anesthesiology at Boston Medical Center (BMC) and professor of anesthesiology at Boston University School of Medicine (BUSM), and his colleagues is featured in this week's New England Journal of Medicine.
NOTE TO EDITORS: Photo available at http://today.uci.edu/news/2011/04/nr_ptips_110421.php Irvine, Calif., April 21, 2011 ? A UC Irvine anesthesiologist will use a $3.2 million National Institutes of Health grant to launch a research effort aime...
Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced that Caldolor® (ibuprofen) Injection is being used by anesthesiologists in a growing number of hospitals and surgery centers to provide preemptive analgesia for surgical patients. In 2009, Caldolor became the first injectable product approved by the FDA with a dual indication for treatment of pain and fever in adults.
The nation’s sole maker of the drug will not resume production because of the controversy over its use in lethal-injection executions. Medscape Medical News
The nation’s sole maker of the drug will not resume production because of the controversy over its use in lethal-injection executions. Medscape Medical News
Syndicate content